Allied Biotech Corp(TW:1780)
NT$23.700.00 (0.00%)
TW:1780
Allied Biotech Corp financials statements
NT$23.70
At close:0.00 (0.00%)
Allied Biotech Corp (1780) Financial Statements
Allied Biotech Corp Financial Overview
Allied Biotech Corp's market cap is currently NT$2.59B. The company's EPS TTM is NT$2.95; its P/E ratio is 8.03; and it has a dividend yield of 5.27%. Allied Biotech Corp has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 849.51M | NT$ 806.92M | NT$ 720.43M | NT$ 716.75M | NT$ 676.76M |
| Gross Profit | NT$ 308.61M | NT$ 258.38M | NT$ 246.44M | NT$ 271.05M | NT$ 258.05M |
| Operating Income | NT$ 120.39M | NT$ 88.11M | NT$ 88.71M | NT$ 101.78M | NT$ 28.82M |
| EBITDA | NT$ 242.44M | NT$ 205.93M | NT$ 204.79M | NT$ 270.55M | NT$ 94.06M |
| Net Income | NT$ 129.46M | NT$ 100.94M | NT$ 97.41M | NT$ 146.74M | NT$ 13.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 853.91M | NT$ 987.24M | NT$ 724.77M | NT$ 793.00M | NT$ 1.14B |
| Total Assets | NT$ 2.09B | NT$ 2.26B | NT$ 2.08B | NT$ 2.18B | NT$ 2.44B |
| Total Debt | NT$ 733.52M | NT$ 955.38M | NT$ 796.61M | NT$ 838.04M | NT$ 1.25B |
| Net Debt | NT$ -55.56M | NT$ -22.95M | NT$ 178.11M | NT$ 158.29M | NT$ 490.08M |
| Total Liabilities | NT$ 857.19M | NT$ 1.06B | NT$ 910.12M | NT$ 999.40M | NT$ 1.36B |
| Stockholders' Equity | NT$ 1.23B | NT$ 1.20B | NT$ 1.17B | NT$ 1.18B | NT$ 1.08B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 183.55M | NT$ 196.98M | NT$ 89.71M | NT$ 109.62M | NT$ 22.44M |
| Operating Cash Flow | NT$ 217.13M | NT$ 223.79M | NT$ 137.62M | NT$ 164.27M | NT$ 72.43M |
| Investing Cash Flow | NT$ -89.49M | NT$ 70.55M | NT$ -40.94M | NT$ 219.02M | NT$ -180.94M |
| Financing Cash Flow | NT$ -319.33M | NT$ 64.94M | NT$ -158.33M | NT$ -462.00M | NT$ 164.24M |
Currency in TWD

